Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026 and Jun 2026.
- Largest single sale: $7.9M (33,000 shares) of Axsome Therapeutics, Inc. on Jun 9, 2026. Filing
- Last sale before this period: Feb 14, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | Chief Financial Officer | May 29, 2018 | Jun 9, 2026 |
Recent filings
The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 9, 2026, Axsome Therapeutics, Inc.: sold 33,000 shares for $7.9M, under a disclosed plan; 33,000 shares acquired by exercising options. 1 filing: 1
- Jan 22, 2026, Axsome Therapeutics, Inc.: sold 12,000 shares for $2.3M, under a disclosed plan; 12,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.